EyePoint, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
EyePoint, Inc. (EYPT) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $0 as of 2018-06-30, per its 10-K filed 2018-09-18.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2018-09-18
- 2018-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2017-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2016-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
- 2015-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $0.00.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value |
|---|---|
| 2018-06-30 | $0.00 10-K · filed 2018-09-18 |
| 2017-06-30 | $0.00 10-K · filed 2018-09-18 |
| 2016-06-30 | $0.00 10-K · filed 2017-09-13 |
| 2015-06-30 | $0.00 10-K · filed 2016-09-13 |
| 2014-06-30 | $0.00 10-K · filed 2015-09-10 |
| 2013-06-30 | $0.00 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |